Market news
CRA International (CRAI) has drawn fresh attention after recent price moves left the consulting specialist trading well below some valuation estimates. The stock closed at US$162.07, with recent returns mixed across different time frames. For CRA International, the recent slide leaves the 1-month share price return down 7.4%, even though the 90-day share price return is up 13.9% and the 3-year total shareholder return is 68.4%. This points to longer term momentum, even as near term enthusiasm...
Third Avenue Management, an investment management company, released its second-quarter 2026 investor letter for the “Third Avenue Small-Cap Value Fund”. You can download the letter here. The Third Avenue Small-Cap Value Fund returned 12.85% in Q2 2026, outperforming the MSCI USA Small Cap Value Index (12.61%) but underperforming the Russell 2000 Value Index (17.19%). Year-to-date, […]
CRA International’s second quarter saw revenue and non-GAAP earnings per share both surpass Wall Street expectations, but the market responded with some caution. Management attributed the company’s performance to double-digit growth across several core practices, including Energy, Life Sciences, and Forensic Services, as well as strong contributions from Antitrust & Competition Economics. CEO Paul Maleh pointed out that both North American and international operations contributed to the top-line
Detailed price information for Cra International (CRAI-Q) from The Globe and Mail including charting and trades.
Detailed price information for Cra International (CRAI-Q) from The Globe and Mail including charting and trades.
Detailed price information for Cra International (CRAI-Q) from The Globe and Mail including charting and trades.
Detailed price information for Cra International (CRAI-Q) from The Globe and Mail including charting and trades.
CRA (CRAI) delivered earnings and revenue surprises of +1.89% and +6.29%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Detailed price information for Cra International (CRAI-Q) from The Globe and Mail including charting and trades.
Detailed price information for Cra International (CRAI-Q) from The Globe and Mail including charting and trades.
Riverwater Partners, an investment management company, released its “Micro Opportunities Strategy” Q2 2026 investor letter. A copy of the letter is available to download here. In Q2 2026, the Micro Opportunities strategy underperformed the Russell Microcap Index, despite a positive absolute result. The benchmark performed well during a speculative period for micro caps. Over the […]
Detailed price information for Cra International (CRAI-Q) from The Globe and Mail including charting and trades.
In July 2026, BriaCell Therapeutics Corp. announced it had engaged Charles River Associates (CRA International) and Kaleio, Inc. to support commercial strategy, market access evaluation, and brand planning for Bria-IMT, its investigational metastatic breast cancer therapy currently in a pivotal Phase 3 trial. This engagement highlights how CRA International’s specialized healthcare and market access expertise is being tapped early in the oncology commercialization process, underscoring its...
Investors need to pay close attention to CRAI stock based on the movements in the options market lately.
Detailed price information for Azz Inc (AZZ-N) from The Globe and Mail including charting and trades.
This is the newest page. Registered accounts read further back.